Sea Crest Wealth Management, LLC Emergent Bio Solutions Inc. Transaction History

Sea Crest Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	BUY	$4.66 - $11.66 $60,580 - $151,580	13,000 Added 13.87%	106,700 $497,000
Q4 2024 Jan 14, 2025	SELL	$7.72 - $11.97 $193,000 - $299,250	-25,000 Reduced 21.06%	93,700 $895,000
Q3 2024 Oct 16, 2024	BUY	$5.72 - $14.77 $21,192 - $54,722	3,705 Added 3.22%	118,700 $991,000
Q2 2024 Jul 19, 2024	BUY	$1.86 - $6.98 $35,330 - $132,585	18,995 Added 19.79%	114,995 $784,000
Q1 2024 Apr 18, 2024	BUY	$1.5 - $3.41 $144,000 - $327,360	96,000 New	96,000 $242,000
Q2 2019 Jul 19, 2019	SELL	$39.92 - $53.86 $3,153 - $4,254	-79 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $1,561 - $1,995	-30 Reduced 27.52%	79 $5,000
Q4 2017 Feb 02, 2018	BUY	$37.77 - $47.75 $4,116 - $5,204	109	109 $5,000

189

39.5M

197K

128K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $444M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.